Incyte Corporation (INCY)

Basic

  • Market Cap

    $12.32B

  • EV

    $8,838.69M

  • Shares Out

    224.11M

  • Revenue

    $3,609.01M

  • Employees

    2,324

Margins

  • Gross

    46.61%

  • EBITDA

    17.37%

  • Operating

    15.09%

  • Pre-Tax

    17.84%

  • Net

    11.78%

  • FCF

    16.1%

Returns (5Yr Avg)

  • ROA

    4.8%

  • ROE

    10.53%

  • ROCE

    9.26%

  • ROIC

    22.28%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $76.62

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    $16.17

  • Earnings (Dil)

    $1.88

  • FCF

    $2.58

  • Book Value

    $22.01

Growth (CAGR)

  • Rev 3Yr

    13.68%

  • Rev 5Yr

    14.96%

  • Rev 10Yr

    25.52%

  • Dil EPS 3Yr

    6.66%

  • Dil EPS 5Yr

    29.58%

  • Dil EPS 10Yr

    28.55%

  • Rev Fwd 2Yr

    10.25%

  • EBITDA Fwd 2Yr

    41.38%

  • EPS Fwd 2Yr

    26.78%

  • EPS LT Growth Est

    27.67%

Dividends

  • Yield

    —

  • Payout

    —

  • DPS

    —

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    —

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Revenues

1,881.7

2,158.8

2,666.7

2,986.3

3,394.6

3,609.0

Other Revenues, Total

0.2

—

—

—

—

—

Total Revenues

1,881.9

2,158.8

2,666.7

2,986.3

3,394.6

3,609.0

Total Revenues % Chg.

22.5%

14.7%

23.5%

12.0%

13.7%

8.4%

Cost of Goods Sold, Total

1,292.1

1,268.4

2,390.1

1,646.2

1,800.9

1,926.9

Gross Profit

589.8

890.4

276.6

1,340.1

1,593.7

1,682.1

Selling General & Admin Expenses, Total

434.9

469.3

517.9

741.0

999.3

1,137.5

Other Operating Expenses, Total

434.9

469.3

517.9

741.0

999.3

1,137.5

Operating Income

154.9

421.1

-241.2

599.1

594.4

544.6

Interest Expense, Total

-1.5

-1.9

-2.2

-1.9

-2.7

-2.4

Interest And Investment Income

—

—

—

—

—

108.7

Net Interest Expenses

-1.5

-1.9

-2.2

-1.9

-2.7

106.3

Other Non Operating Income (Expenses)

32.3

52.7

24.2

12.1

37.1

37.1

EBT, Excl. Unusual Items

185.6

472.0

-219.3

609.3

628.9

688.0

Merger & Related Restructuring Charges

—

—

—

—

—

—

Gain (Loss) On Sale Of Investments

-44.1

34.5

10.4

-24.1

-87.6

-5.6

Asset Writedown

—

—

—

—

—

—

Other Unusual Items

-26.2

-19.7

-23.4

-14.7

-12.1

-38.5

EBT, Incl. Unusual Items

115.3

486.8

-232.2

570.4

529.1

643.9

Income Tax Expense

5.9

39.9

63.5

-378.1

188.5

218.9

Earnings From Continuing Operations

109.5

446.9

-295.7

948.6

340.7

425.0

Net Income

109.5

446.9

-295.7

948.6

340.7

425.0

Net Income to Common Incl Extra Items

109.5

446.9

-295.7

948.6

340.7

425.0

Net Income to Common Excl. Extra Items

109.5

446.9

-295.7

948.6

340.7

425.0

Total Shares Outstanding

213.3

216.2

219.5

221.1

222.7

224.1

Weighted Avg. Shares Outstanding

212.4

214.9

218.1

220.4

222.0

223.2

Weighted Avg. Shares Outstanding Dil

215.6

217.7

218.1

222.1

224.0

225.6

EPS

0.5

2.1

-1.4

4.3

1.5

1.9

EPS Diluted

0.5

2.1

-1.4

4.3

1.5

1.9

EBITDA

209.8

475.7

-186.8

659.7

665.3

626.8